Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Return on Capital Employed (2018 - 2021)

Cogent Biosciences has reported Return on Capital Employed over the past 4 years, most recently at 0.3% for Q3 2021.

  • Quarterly results put Return on Capital Employed at 0.3% for Q3 2021, up 75.0% from a year ago — trailing twelve months through Sep 2021 was 0.3% (up 75.0% YoY), and the annual figure for FY2020 was 0.6%, down 1.0%.
  • Return on Capital Employed for Q3 2021 was 0.3% at Cogent Biosciences, up from 0.45% in the prior quarter.
  • Over the last five years, Return on Capital Employed for COGT hit a ceiling of 0.3% in Q3 2021 and a floor of 1.16% in Q1 2018.
  • Median Return on Capital Employed over the past 4 years was 0.71% (2019), compared with a mean of 0.7%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -64bps in 2019 and later soared 75bps in 2021.
  • Cogent Biosciences' Return on Capital Employed stood at 0.55% in 2018, then crashed by -45bps to 0.8% in 2019, then skyrocketed by 43bps to 0.45% in 2020, then skyrocketed by 34bps to 0.3% in 2021.
  • The last three reported values for Return on Capital Employed were 0.3% (Q3 2021), 0.45% (Q2 2021), and 0.38% (Q1 2021) per Business Quant data.